• STING Signaling Links Bile Acid Stress to Cholangiocyte Sene

  2026-05-21

  This study demonstrates that conjugated bile acids drive cholangiocyte senescence and inflammation in cholestatic liver diseases through STING pathway activation. By dissecting molecular mechanisms in both human and mouse models, the work identifies STING as a promising target for therapeutic intervention.

• Hexa His Tag Peptide: Streamlining 6X His-Tagged Protein Pur

  2026-05-20

  The Hexa His tag peptide delivers precise, antibody-free elution in 6X His-tagged protein purification workflows. By leveraging its high solubility and competitive binding, researchers achieve cleaner results and robust reproducibility, making it an essential tool for advanced protein interaction studies.

• Tioconazole and the Future of Translational Antifungal Resea

  2026-05-20

  Explore how Tioconazole’s mechanistic specificity in ergosterol biosynthesis inhibition, robust formulation, and validated research-grade purity are empowering translational researchers to dissect fungal biology and bridge insights into metabolic-genomic crosstalk. This thought-leadership article provides strategic guidance for antifungal drug development, integrating evidence from recent discoveries on the interplay between cellular energy, DNA repair, and fungal pathogenesis, and situates Tioconazole as a pivotal asset in advancing reproducible, clinically meaningful fungal infection models.

• PKH26 Red Fluorescent Cell Linker Kit: Technical Protocol Gu

  2026-05-19

  The PKH26 Red Fluorescent Cell Linker Kit enables robust, stable labeling of cell membrane lipid regions for cell tracing and proliferation studies. It is best suited for membrane-focused applications in both in vitro and in vivo research and should not be used for labeling intracellular structures or non-membrane targets.

• Clathrin-Mediated Entry of Grass Carp Reovirus: Inhibitor Ev

  2026-05-19

  Wang et al. (2018) established that genotype III grass carp reovirus (GCRV104) enters host cells through clathrin-mediated, pH-dependent endocytosis, rather than via pathways involving actin cytoskeleton disruption. This clarification of viral entry mechanisms provides a foundation for targeted antiviral research and informs the rational use of cytoskeletal inhibitors in related cellular studies.

• Dihydroartemisinin (SKU N1713): Optimizing Cell Assays & Mal

  2026-05-18

  This authoritative guide explores how Dihydroartemisinin (SKU N1713), a high-purity Artemisia plant extract, overcomes reproducibility, solubility, and workflow challenges in cell viability and malaria research assays. Integrating scenario-driven Q&A, real-world protocol parameters, and evidence-based vendor comparisons, this article helps bench scientists and biomedical researchers achieve robust experimental outcomes with confidence.

• Autophagy–Liver Metastasis Signature Predicts CRC Prognosis

  2026-05-18

  Bai et al. (2026) developed a prognostic gene signature for colorectal cancer by integrating autophagy and liver metastasis pathways using bulk and single-cell transcriptomic analyses. This signature robustly predicts patient outcomes and reveals mechanistic links between tumor biology, immune evasion, and therapeutic resistance, guiding future biomarker-driven research.

• Blue Light Damages Skin Barrier via EGFR/ERK/c-Jun Pathway

  2026-05-17

  This study delineates how blue light (BL) irradiation impairs the human skin barrier through activation of the EGFR/ERK/c-Jun signaling pathway, leading to epidermal thickening, pigmentation, and functional compromise. These findings provide mechanistic insight into visible light-induced dermal pathology and establish a platform for future investigations into EGFR-targeted interventions.

• Troglitazone as a PPARγ Agonist: Advanced Protocols in TAM R

  2026-05-16

  Troglitazone is transforming tumor microenvironment research as a dual PPARγ/α agonist, enabling precise SPP1 modulation and apoptosis induction in TAM-rich tumors. This guide demystifies workflow optimization, protocol pitfalls, and the translational impact of Troglitazone for applied diabetes and oncology studies.

• G-15: Precision G Protein-Coupled Estrogen Receptor Antagoni

  2026-05-15

  G-15, a selective G protein-coupled estrogen receptor antagonist from APExBIO, offers researchers a robust tool for dissecting GPR30-mediated estrogen signaling. This guide details actionable workflows, advanced applications, and troubleshooting strategies to maximize the specificity and reproducibility of G-15-driven experiments.

• Tacalcitol Monohydrate: Vitamin D3 Analog for Translational

  2026-05-15

  Tacalcitol monohydrate, a synthetic analog of vitamin D3, delivers reproducible NGF induction and enhances 5-fluorouracil efficacy across dermatology and oncology settings. Explore robust, evidence-backed workflows and troubleshooting strategies leveraged by APExBIO’s rigorously validated reagent.

• Biotin-HPDP in Translational Protein Labeling: Mechanism to

  2026-05-14

  This thought-leadership article explores how Biotin-HPDP (N-[6-(biotinamido)hexyl]-3’-(2’-pyridyldithio)propionamide) reshapes thiol-specific protein labeling in translational research, especially in the context of tumor immunometabolism. By integrating mechanistic insights, competitive benchmarking, and strategic guidance for translational scientists, it highlights the reagent’s role in dissecting redox and post-translational modifications central to immune evasion and therapeutic development.

• High-Throughput BBB Model: Predicting CNS Drug Permeability

  2026-05-14

  This study introduces a high-throughput, physiologically relevant in vitro blood-brain barrier (BBB) model integrating LLC-PK1-MOCK/MDR1 cell lines and lysosomal trapping correction, enabling accurate prediction of brain permeability for CNS drug candidates. The model demonstrates robust correlation with in vivo brain distribution, streamlining early-stage neurological drug screening and reducing the need for animal testing.

• PPM-18: Strategic iNOS Inhibition for Translational Research

  2026-05-13

  This thought-leadership article explores the mechanistic underpinnings and translational strategy for leveraging PPM-18 (N-(1,4-dihydro-1,4-dioxo-2-naphthalenyl)-benzamide) in inflammation and sepsis research. By integrating recent insights into NF-κB-driven iNOS regulation, in vivo validation, and lessons from cardiovascular peptide signaling, we provide a roadmap for researchers to maximize the impact of PPM-18 across preclinical workflows. This piece escalates the discussion beyond standard product summaries, emphasizing experimental design, protocol precision, and the competitive landscape.

• Proteinase K: Advanced Strategies for DNA Integrity & Transl

  2026-05-13

  This thought-leadership article delivers a mechanistic deep dive and actionable strategic guidance for translational researchers using Proteinase K—a broad-spectrum serine protease pivotal for genomic DNA isolation and protein hydrolysis in molecular biology. By integrating the latest evidence, benchmarking competitive enzymatic platforms, and providing protocol parameters with transparent sourcing, we empower scientists to optimize DNA integrity, contaminant removal, and reproducible workflows. The article uniquely bridges current innovation with future-ready strategies, highlighting APExBIO’s recombinant Proteinase K and its role in advancing the reliability and scalability of molecular biology assays.

460 records 18/31 page Previous Next First page 上5页 1617181920 下5页 Last page